
The top 5 OncLive TV videos of the week cover insights in HER2+ breast cancer, NSCLC, ovarian cancer, prostate cancer, and sarcoma.
Tian Zhang, MD, a medical instructor in the Department of Medicine, Duke University School of Medicine, discusses the impact of the LATITUDE study in prostate cancer.
Tian Zhang, MD, a medical instructor in the Department of Medicine, Duke University School of Medicine, discusses the impact of the LATITUDE study in prostate cancer.
Median progression-free survival and overall survival were both markedly improved with the addition of abiraterone acetate (Zytiga) to standard androgen-deprivation therapy (ADT) compared with ADT alone in patients with newly diagnosed, high-risk, metastatic prostate cancer.






